Can Levosimendan Be a Treatment Option in Subarachnoid Hemorrhage?

Journal Title: Türk Yoğun Bakım Dergisi - Year 2018, Vol 16, Issue 2

Abstract

Despite improvements in medical and surgical treatment, aneurysmatic subarachnoid hemorrhage (SAH) remains one of the main causes of early mortality. Cardiac and pulmonary complications are the main causes of mortality. One of the most severe cardiac complications is neurogenic stress cardiomyopathy. Left ventricular dysfunction which is seen in neurogenic stress cardiomyopathy, although it is usually reversible within a few days, can cause severe hypotension, pulmonary edema and cardiogenic shock. Traditional treatment of heart failure after SAH is based on the use of noradrenaline, dobutamine and high volume of fluids. However, it is difficult to treat reduced cardiac output in SAH. Because, myocardial cells are already under stress due to increased adrenergic stimulation. The use of exogenous catecholamines may cause additional neurocardiogenic damage in myocardial cells, excessive calcium burden, decreased cerebral blood flow, and delayed cerebral ischemia. By reducing the use of exogenous catecholamines with levosimendan, the vicious circle of cardiotoxicity induced by catecholamines can be broken. Levosimendan is a nonadrenergic inotropic calcium sensitizer that allows rapid recovery of cardiac output and optimizes cerebral perfusion without increasing myocardial oxygen consumption. If we consider that reduction in left ventricular systolic function plays a role in the pathogenesis of delayed cerebral ischemia, the risk of developing neurological complications may be reduced by administration of levosimendan in these patients. Moreover, new evidence from experimental studies also indicates that levosimendan may have neuroprotective effects in the SAH. In this review, the use of levosimendan in the treatment of hemodynamic disorders which develops in the course of SAH has been discussed in company with current literature.

Authors and Affiliations

Tuğçe Mengi, Barış Yılmaz, Ali Necati Gökmen, Uğur Koca

Keywords

Related Articles

Home Mechanical Ventilation in Children: Erciyes University Experience

Objective: In this study it was aimed to share experiences and to draw attention to the problems about home mechanical ventilation (HMV) which is used in the treatment of patients with chronic respiratory failure and is...

Evaluation of Gram-Negative Bacilli Isolated from Patients in Intensive Care Units

Objective: A significant proportion of nosocomial infections resulting in significant mortality and morbidity for hospitalized patients are due to the patients in intensive care units (ICU). For this reason, the identifi...

A Rare Case: Brugada Syndrome

Brugada syndrome is an electrocardiography (ECG) abnormality with a high incidence of sudden death in patients. It is characterized by typical ECG abnormalities such as ST elevation in precordial leads. Brugada syndrome...

Spontaneous Repetitive Tracheal Rupture

Tracheal ruptures are one of the life-threatening situations in critical care unit and can be formed after trauma, intubation, tracheotomy, bronchoscopy or spontaneously. Significant risk factors for tracheal rupture inc...

Thirty-day Mortality Outcomes of Trauma Patients in the Intensive Care Unit: A Three-year Retrospective Study

Objective: In this study, we aimed to investigate the characteristics of trauma patients hospitalized in intensive care units of a hospital, the first 30-day mortality rates and the causes affecting mortality in this per...

Download PDF file
  • EP ID EP382223
  • DOI 10.4274/tybd.05025
  • Views 120
  • Downloads 0

How To Cite

Tuğçe Mengi, Barış Yılmaz, Ali Necati Gökmen, Uğur Koca (2018). Can Levosimendan Be a Treatment Option in Subarachnoid Hemorrhage?. Türk Yoğun Bakım Dergisi, 16(2), 50-57. https://europub.co.uk/articles/-A-382223